Hydrates deeply for a supple and vibrant complexion without leaving a greasy residue
Angiogenesis Promotes new blood vessel formation in damaged tissue by stimulating VEGF expression, creating vascular networks that deliver healing resources to the injury site
DSIP works more directly on sleep architecture, enhancing deep sleep phases regardless of baseline anxiety levels
Each compound is dosed once weekly and titrated slowly
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Ons Proces Gemaakt in een gecertificeerde EU-faciliteit volgens strikte farmaceutische normen voor bereidingen